Diego Flichman

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

Carlos J. Pirola, Tomas Fernández Gianotti, Gustavo Castaño et al. · Gut · 2014 · 540 citations · Full text

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease

Carlos J. Pirola, Martín Garaycoechea, Diego Flichman et al. · Journal of Lipid Research · 2018 · 132 citations · Full text

Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level

Silvia Sookoian, Gustavo Castaño, Romina Scian et al. · American Journal of Clinical Nutrition · 2016 · 125 citations · Full text

Metabolic Syndrome, Hepatology, Biochemistry +13

Mitochondrial genome architecture in non‐alcoholic fatty liver disease

Silvia Sookoian, Diego Flichman, Romina Scian et al. · The Journal of Pathology · 2016 · 80 citations · Full text

Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease

Silvia Sookoian, Diego Flichman, Martín Garaycoechea et al. · Scientific Reports · 2018 · 56 citations · Full text